(CNN) — President Donald Trump on Thursday announced an agreement to sell common fertility drugs at steeply reduced prices on TrumpRx, a direct-to-consumer drug platform the White House plans to launch in January 2026.

Under the plan, cost to patients for three in vitro fertilization (IVF) drugs made by EMD Serono, the US arm of German company Merck KGaA, could be reduced by more than 70%, Trump and administration officials said.

The drugs, sold under the brand names Gonal-F, Ovidrel and Cetrotide, currently typically cost $5,000 per IVF cycle, the president said.

“As part of this agreement, EMD Serono will list their fertility drugs online at TrumpRx.gov at very, very heavily reduced prices — prices that you won’t even believe,” Trump said, calling the company largest fertility drug m

See Full Page